Cipla Limited — Updates, 29-05-2025: Incorporation

Cipla has announced a board meeting to discuss the financial results for the quarter and half-year. Its UK subsidiary, Cipla (EU) Limited, has set up a wholly owned German subsidiary, CiplaRna GmbH, to focus on mRNA-based formulations and drug development support. This strategic expansion into advanced pharma research strengthens Cipla’s innovation capabilities and could boost its long-term growth potential. The new entity was funded through a cash investment of 25,000 shares at par value.